suppress differentiation into osteoclasts but not into macrophages Two histone deacetylase inhibitors, trichostatin A and sodium butyrate,

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Osteoclasts: Inability to Replace Its Activity with IL-2

  2013cited by this paper
• JDP2, a Repressor of AP-1, Recruits a Histone Deacetylase 3 Complex To Inhibit the Retinoic Acid-Induced Differentiation of F9 Cells

  2002cited by this paper
• Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatment.

  2002cited by this paper
• Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene.

  2002cited by this paper
• The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines

  2002cited by this paper
• The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1

  2002cited by this paper
• Loss of PU.1 Expression Following Inhibition of Histone Deacetylases1

  2001cited by this paper
• Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-κB Ligand (RANKL)-induced JNK Activation*

  2001cited by this paper
• Segregation of TRAF6‐mediated signaling pathways clarifies its role in osteoclastogenesis

  2001cited by this paper
• Histone deacetylases and cancer: causes and therapies

  2001cited by this paper
• Tumor necrosis factor-α cooperates with receptor activator of nuclear factor κB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture

  2001cited by this paper
• Butyrate Suppression of Colonocyte NF-κB Activation and Cellular Proteasome Activity*

  2001cited by this paper
• Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation

  2001cited by this paper
• Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report.

  2001cited by this paper
• Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.

  2001cited by this paper
• Transcriptional Induction of MKP-1 in Response to Stress Is Associated with Histone H3 Phosphorylation-Acetylation

  2001cited by this paper
• The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line.

  2000cited by this paper
• Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL)*

  2000cited by this paper
• Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation

  2000cited by this paper
• Tumor Necrosis Factor (cid:97) Stimulates Osteoclast Differentiation by a Mechanism Independent of the ODF/RANKL–RANK Interaction

  2000cited by this paper
• The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells

  2000cited by this paper
• Identification and Characterization of the New Osteoclast Progenitor with Macrophage Phenotypes Being Able to Differentiate into Mature Osteoclasts

  2000cited by this paper
• Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression

  2000cited by this paper
• Activation of p38 mitogen‐activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor

  2000cited by this paper
• Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.

  2000cited by this paper
• SN-1, a novel leukemic cell line with t(11;16)(q23;p13): myeloid characteristics and resistance to retinoids and vitamin D3.

  2000cited by this paper
• Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis

  2000cited by this paper
• Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

  1999cited by this paper
• Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice

  1999cited by this paper
• Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

  1999cited by this paper
• High‐level expression of IκB‐β in the surface epithelium of the colon: in vitro evidence for an immunomodulatory role

  1999cited by this paper
• TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.

  1999cited by this paper
• Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy

  1999cited by this paper
• A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture

  1999cited by this paper
• Osteoclast-Derived Zinc Finger (OCZF) Protein With POZ Domain, a Possible Transcriptional Repressor, Is Involved in Osteoclastogenesis

  1999cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• Regulation of activity of the transcription factor GATA-1 by acetylation

  1998cited by this paper
• RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.

  1998cited by this paper
• Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts.

  1998cited by this paper
• Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase.

  1997cited by this paper
• Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

  1997cited by this paper
• CD11c integrin gene promoter activity during myeloid differentiation.

  1997cited by this paper
• Osteopetrosis in mice lacking NF-κB1 and NF-κB2

  1997cited by this paper
• Requirement for NF-κB in osteoclast and B-cell development

  1997cited by this paper
• Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts.

  1997cited by this paper
• Human fetal enterocytes in vitro: modulation of the phenotype by extracellular matrix.

  1996cited by this paper
• Granulocyte-macrophage colony-stimulating factor, phorbol ester, and sodium butyrate induce the CD11c integrin gene promoter activity during myeloid cell differentiation.

  1995cited by this paper
• Calcitonin receptor isoforms in mouse and rat osteoclasts

  1995cited by this paper
• In vitro differentiation of the murine macrophage cell line BDM-1 into osteoclast-like cells.

  1995cited by this paper
• Interleukin‐10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast‐like cells in rat bone marrow culture system

  1995cited by this paper
• Regulation of c‐myc expression by sodium butyrate in the colon carcinoma cell line Caco‐2

  1993cited by this paper
• Induction of mononuclear precursor cells with osteoclastic phenotypes in a rat bone marrow culture system depleted of stromal cells.

  1993cited by this paper
• Effects of short chain fatty acid, sodium butyrate, on osteoblastic cells and osteoclastic cells.

  1993cited by this paper
• Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells.

  1993cited by this paper
• Modulation of osteoclast differentiation.

  1992cited by this paper
• TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown.

  1992cited by this paper
• Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.

  1992cited by this paper
• Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix.

  1991cited by this paper
• Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.

  1990cited by this paper
• The induction of vimentin gene expression by sodium butyrate in human promonocytic leukemia U937 cells.

  1990cited by this paper
• [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A].

  1990cited by this paper
• Generation of osteoclasts from isolated hematopoietic progenitor cells.

  1989cited by this paper
• Evidence for expression of the facilitated glucose transporter in rat hepatocytes.

  1988cited by this paper
• Sodium butyrate and a T lymphocyte cell line-derived differentiation factor induce basophilic differentiation of the human promyelocytic leukemia cell line HL-60.

  1988cited by this paper
• Effects of trichostatins on differentiation of murine erythroleukemia cells.

  1987cited by this paper
• The osteoclast and periodontitis.

  1986cited by this paper
• In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes

  1982cited by this paper

• Nox2 Activity Is Required in Obesity-Mediated Alteration of Bone Remodeling

  2018cites this paper